Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
1(10%)
Results Posted
86%(6 trials)
Terminated
1(10%)

Phase Distribution

Ph phase_1
2
20%
Ph not_applicable
1
10%
Ph phase_3
2
20%
Ph phase_2
5
50%

Phase Distribution

2

Early Stage

5

Mid Stage

2

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
2(20.0%)
Phase 2Efficacy & side effects
5(50.0%)
Phase 3Large-scale testing
2(20.0%)
N/ANon-phased studies
1(10.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(7)
Terminated(1)

Detailed Status

Completed7
Not yet recruiting1
Terminated1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
87.5%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (20.0%)
Phase 25 (50.0%)
Phase 32 (20.0%)
N/A1 (10.0%)

Trials by Status

not_yet_recruiting110%
terminated110%
recruiting110%
completed770%

Recent Activity

1 active trials
Showing 5 of 10
completedphase_1

Clinical Trial to Evaluate UV-light-induced Allergic Skin Reactions After Application of Delgocitinib Cream

NCT04807751
completedphase_1

Clinical Trial to Evaluate Light-induced Skin Reactions After Application of Delgocitinib Cream

NCT04361136
not_yet_recruitingnot_applicable

The Role of Janus Kinase (JAK) and Voltage-gated Sodium Channels (Nav) on Pain and Itch

NCT07203274
recruitingphase_2

A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis

NCT07013201
completedphase_3

Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema

NCT04871711
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT04807751Phase 1

Clinical Trial to Evaluate UV-light-induced Allergic Skin Reactions After Application of Delgocitinib Cream

Completed
NCT04361136Phase 1

Clinical Trial to Evaluate Light-induced Skin Reactions After Application of Delgocitinib Cream

Completed
NCT07203274Not Applicable

The Role of Janus Kinase (JAK) and Voltage-gated Sodium Channels (Nav) on Pain and Itch

Not Yet Recruiting
NCT07013201Phase 2

A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis

Recruiting
NCT04871711Phase 3

Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema

Completed
NCT04872101Phase 3

Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema (DELTA 2)

Completed
NCT03683719Phase 2

Phase 2b Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over a 16-week Treatment Period in Adult Subjects With Chronic Hand Eczema

Completed
NCT03725722Phase 2

Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over an 8-week Treatment Period in Adult Subjects With Atopic Dermatitis.

Completed
NCT05332366Phase 2

A Trial to Assess the Effect of Delgocitinib Cream 20 mg/g on the Molecular Signature, Safety, and Efficacy in Adults With Frontal Fibrosing Alopecia

Completed
NCT03958955Phase 2

Efficacy and Safety of Delgocitinib Cream in Discoid Lupus Erythematosus.

Terminated

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10